Rebalix
Logo AmundiAmundi · sheet of 5 September 2026
ETF sheet · official issuer and register data

Amundi EURO STOXX 50 II UCITS ETF S - Acc

MSES · FR001400ZGP1 · class S - Acc · EUR · domicile France
Equity · Eurozone · Large capSFDR art. 6
Index tracked: EURO STOXX 50 Net Return EUR
TER
0.20%+ trans. 0.02%
Fund size
5 m EUR
Tracking difference
not computable
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Accumulating
Launch 3 Jun 2025 · costs from the KID as of 2 Sept 2026 · 57 securities held · 5 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is a passively managed index-based UCITS. The Fund's objective is to replicate the performance, both upwards and downwards, of the EURO STOXX 50 Net Return Index (net dividends reinvested) (the "Benchmark"), denominated in euro (EUR) and representative of 50 investment grade Eurozone securities, while minimising the tracking error between the Fund's performance and that of the Benchmark. The expected level of the Tracking Error under normal market conditions is indicated in the Fund prospectus. The website http://www.stoxx.com/indices provides…

Performance since series start (in euro) — base 100

3 Jun 20253 Sept 2026 · dividends reinvested where declared by the issuer
202612596122
High 125 (11 Aug 2026) · low 96 (1 Aug 2025) · last 122. Past performance is not indicative of future results.

Returns in euro

1 year+23.7%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+22.0%

Risk · 1 / 3 / 5 years

Volatility (ann.)15.45%15.45%
Max drawdown−10.89%−10.89%
Sharpe1.251.25
Sortino1.991.99
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · MSES · FR001400ZGP11
RebalixMSES · FR001400ZGP1 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 57 securities · top-10 weight = 42.0%
Top holdingsWeight
ASML HOLDING NV8.6%
SIEMENS AG-REG4.6%
SAP SE / XETRA4.2%
BANCO SANTANDER SA MADRID4.2%
TOTALENERGIES SE PARIS4.0%
ALLIANZ SE-REG3.9%
SCHNEIDER ELECT SE3.8%
BANCO BILBAO VIZCAYA ARGENTA3.2%
UNICREDIT SPA2.8%
IBERDROLA SA2.8%
Countries (% of fund)
France31.9%Germany30.0%Netherlands13.4%Spain11.6%Italy8.8%
Sectors (% of fund)
Financials28.8%Industrials21.4%Information Technology14.5%Consumer Discretionary9.4%Health Care5.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
AE5J · Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
MSES · Euronext Paris
+ 15 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.com.hk/pdfDocuments/kid-priips/FR001400ZGP1/ENG/HKG
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR001400ZGP1/FRA/FRA/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR001400ZGP1/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/FR001400ZGP1
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · MSES · FR001400ZGP12